Maternal serum vascular endothelial growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment

• Published in: Fertility and sterility Vol. 82; no. 2; pp. 309 - 313
• Main Authors: Fasouliotis, Sozos J, Spandorfer, Steven D, Witkin, Steven S, Liu, Hung-Ching, Roberts, Jeffrey E, Rosenwaks, Zev
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.08.2004; Elsevier Science
• Subjects: Abortion, Spontaneous - blood; Adult; Biological and medical sciences; Chorionic Gonadotropin, beta Subunit, Human - blood; Diseases of mother, fetus and pregnancy; Ectopic pregnancy; Embryo Transfer; Female; Fertilization in Vitro - adverse effects; Fertilization in Vitro - methods; Gynecology. Andrology. Obstetrics; Humans; intrauterine pregnancy; IVF; Medical sciences; Oocytes - cytology; Pregnancy - blood; Pregnancy Trimester, First; Pregnancy, Ectopic - blood; Pregnancy. Fetus. Placenta; Progesterone - blood; Retrospective Studies; Vascular Endothelial Growth Factor A - blood; VEGF; IVF; Ectopic pregnancy; VEGF; intrauterine pregnancy; Human; Pregnancy disorders; Fertilization; Assisted procreation; In vitro; Embryo transfer; Vascular endothelium growth factor; Treatment; Female; Early pregnancy

To determine whether serum levels of vascular endothelial growth factor (VEGF) 11 days after a day-3 embryo transfer were predictive of outcome, in women with normal intrauterine pregnancy (IUP), first-trimester miscarriage (SAB), biochemical (BC), and ectopic pregnancy (EP) after IVF therapy. Retro...